Bowhead Specialty Holdings Inc. (NYSE:BOW - Get Free Report) has received a consensus rating of "Moderate Buy" from the six brokerages that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $39.67.
Several analysts have recently weighed in on BOW shares. Keefe, Bruyette & Woods lifted their target price on Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a research report on Friday, May 9th. JPMorgan Chase & Co. boosted their price objective on shares of Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research report on Tuesday, April 8th. Piper Sandler started coverage on shares of Bowhead Specialty in a research note on Wednesday, April 16th. They set an "overweight" rating and a $44.00 price target for the company. Morgan Stanley boosted their price target on Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. Finally, JMP Securities raised their price objective on Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a report on Friday, April 11th.
Check Out Our Latest Research Report on BOW
Bowhead Specialty Stock Up 0.8%
NYSE:BOW traded up $0.28 during mid-day trading on Thursday, hitting $36.30. 137,919 shares of the stock traded hands, compared to its average volume of 198,216. Bowhead Specialty has a 52 week low of $23.70 and a 52 week high of $42.29. The stock has a market capitalization of $1.19 billion and a price-to-earnings ratio of 27.71. The firm's 50 day moving average is $38.89 and its two-hundred day moving average is $36.04.
Bowhead Specialty (NYSE:BOW - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.34 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.01. The business had revenue of $174.85 million for the quarter, compared to the consensus estimate of $105.17 million. As a group, research analysts predict that Bowhead Specialty will post 1.36 EPS for the current year.
Hedge Funds Weigh In On Bowhead Specialty
Large investors have recently bought and sold shares of the business. Summit Investment Advisors Inc. boosted its position in Bowhead Specialty by 66.4% during the 4th quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock valued at $43,000 after acquiring an additional 486 shares in the last quarter. SBI Securities Co. Ltd. purchased a new stake in shares of Bowhead Specialty during the 1st quarter worth $44,000. Nemes Rush Group LLC bought a new stake in Bowhead Specialty during the first quarter valued at about $61,000. New York State Common Retirement Fund bought a new stake in Bowhead Specialty during the fourth quarter valued at about $64,000. Finally, US Bancorp DE purchased a new position in Bowhead Specialty in the fourth quarter valued at about $76,000.
Bowhead Specialty Company Profile
(
Get Free ReportBowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
See Also

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.